Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Akamatsu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Immunity, Inflammation and Disease|July 26, 2024
Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralizationVeronica A de Lima, João P S Nunes, Daniela S Rosa, et al.
Plos One|March 29, 2020
New strategies for Leptospira vaccine development based on LPS removalFabiana Lauretti-Ferreira, Paloma L D Silva, Naiara M Alcântara, et al.
Plos One|March 2, 2017
Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a modelRafaianne Q Moraes-Souza, Ana Paula Reinaque, Thaigra S Soares, et al.
Plos One|October 18, 2022
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trialTazio Vanni, Beatriz C Thomé, Erin Sparrow, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Immunity, Inflammation and Disease|July 26, 2024
Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralizationVeronica A de Lima, João P S Nunes, Daniela S Rosa, et al.
Plos One|March 29, 2020
New strategies for Leptospira vaccine development based on LPS removalFabiana Lauretti-Ferreira, Paloma L D Silva, Naiara M Alcântara, et al.
Plos One|March 2, 2017
Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a modelRafaianne Q Moraes-Souza, Ana Paula Reinaque, Thaigra S Soares, et al.
Plos One|October 18, 2022
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trialTazio Vanni, Beatriz C Thomé, Erin Sparrow, et al.
Pageof 4